These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 9435863)
1. Bispecific-Ab-based immunoassay of thyroid-stimulating hormone. Inouye K Cancer Immunol Immunother; 1997; 45(3-4):159-61. PubMed ID: 9435863 [TBL] [Abstract][Full Text] [Related]
2. A sensitive enzyme immunoassay of human thyroid-stimulating hormone (TSH) using bispecific F(ab')2 fragments recognizing polymerized alkaline phosphatase and TSH. Morimoto K; Inouye K J Immunol Methods; 1997 Jun; 205(1):81-90. PubMed ID: 9236918 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')2 bispecific monoclonal antibody. Negri DR; Tosi E; Valota O; Ferrini S; Cambiaggi A; Sforzini S; Silvani A; Ruffini PA; Colnaghi MI; Canevari S Br J Cancer; 1995 Oct; 72(4):928-33. PubMed ID: 7547242 [TBL] [Abstract][Full Text] [Related]
4. Use of high-capacity surface with oriented recombinant antibody fragments in a 5-min immunoassay for thyroid-stimulating hormone. Brockmann EC; Vehniäinen M; Pettersson K Anal Biochem; 2010 Jan; 396(2):242-9. PubMed ID: 19818328 [TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo. Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to placental alkaline phosphatase: preclinical evaluation in a human xenograft tumour model of F(ab')2 and Fab fragments. Durbin H; Milligan EM; Mather SJ; Tucker DF; Raymond R; Bodmer WF Int J Cancer Suppl; 1988; 2():59-66. PubMed ID: 3162446 [TBL] [Abstract][Full Text] [Related]
7. Bispecific monoclonal antibodies against a viral and an enzyme: utilities in ultrasensitive virus ELISA and phage display technology. Liu F; Guttikonda S; Suresh MR J Immunol Methods; 2003 Mar; 274(1-2):115-27. PubMed ID: 12609538 [TBL] [Abstract][Full Text] [Related]
8. Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigen. Karacay H; Sharkey RM; McBride WJ; Griffiths GL; Qu Z; Chang K; Hansen HJ; Goldenberg DM Bioconjug Chem; 2002; 13(5):1054-70. PubMed ID: 12236788 [TBL] [Abstract][Full Text] [Related]
9. Bispecific rabbit Fab'-bovine serum albumin conjugate used in hemagglutination immunoassay for beta-microseminoprotein. Yukawa N; Osawa M; Saito T; Hasegawa T; Matsuda H; Takahama K; Takeichi S J Immunoassay; 1997 Aug; 18(3):215-33. PubMed ID: 9257262 [TBL] [Abstract][Full Text] [Related]
10. Method for the preparation of bispecific F(ab')2mu fragments from mouse monoclonal antibodies of the immunoglobulin M class and characterization of the fragments. Morimoto K; Inouye K J Immunol Methods; 1999 Apr; 224(1-2):43-50. PubMed ID: 10357205 [TBL] [Abstract][Full Text] [Related]
11. Bispecific F (ab')2 monomer prepared with anti-CD3 and anti-tumor monoclonal antibodies is most potent in induction of cytolysis of human T cells. Nitta T; Yagita H; Azuma T; Sato K; Okumura K Eur J Immunol; 1989 Aug; 19(8):1437-41. PubMed ID: 2528460 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of bifunctional antibodies for immunoassays. DeSilva BS; Wilson GS Methods; 2000 Sep; 22(1):33-43. PubMed ID: 11020315 [TBL] [Abstract][Full Text] [Related]
13. Tumor targeting with newly designed biparatopic antibodies directed against two different epitopes of the carcinoembryonic antigen (CEA). Robert B; Dorvillius M; Buchegger F; Garambois V; Mani JC; Pugnières M; Mach JP; Pèlegrin A Int J Cancer; 1999 Apr; 81(2):285-91. PubMed ID: 10188732 [TBL] [Abstract][Full Text] [Related]
14. Anti-CD3 x anti-tumor F(ab')2 bifunctional antibody activates and retargets tumor-infiltrating lymphocytes. Chapoval AI; Nelson H; Thibault C J Immunol; 1995 Aug; 155(3):1296-303. PubMed ID: 7636196 [TBL] [Abstract][Full Text] [Related]
15. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains. Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801 [TBL] [Abstract][Full Text] [Related]
16. Studies of possible antiidiotypic control mechanisms in Graves' disease. Moynier M; Montano J; Williams RC; Pathak D; DeGroot LC; Hill BL; Marshall NJ J Lab Clin Med; 1988 Jul; 112(1):99-108. PubMed ID: 2839588 [TBL] [Abstract][Full Text] [Related]
17. Chimeric bispecific OC/TR monoclonal antibody mediates lysis of tumor cells expressing the folate-binding protein (MOv18) and displays decreased immunogenicity in patients. Luiten RM; Warnaar SO; Sanborn D; Lamers CH; Bolhuis RL; Litvinov SV; Zurawski VR; Coney LR J Immunother; 1997 Nov; 20(6):496-504. PubMed ID: 9409456 [TBL] [Abstract][Full Text] [Related]
20. [Anti-tumor effects of bispecific monoclonal antibody targeted human monocytes-macrophages on hepatoma cells]. Wang Q; Chen Z; Wang W Zhonghua Yi Xue Za Zhi; 1996 Feb; 76(2):96-9. PubMed ID: 8758438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]